We are live on
!
Find out more
MIM
Monashee Investment Management Portfolio holdings
AUM
$184M
1-Year Est. Return
197.43%
This Fund
S&P 500
This Quarter
Est. Return
+34.76%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$276M
AUM Growth
-$569M
(-67%)
Cap. Flow
-$602M
Cap. Flow
% of AUM
-218.32%
Top 10 Holdings %
Top 10 Hldgs %
44.93%
Holding
96
New
49
Increased
4
Reduced
2
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$15.5M |
| 2 |
GLXY
Galaxy Digital Inc
GLXY
|
+$9.54M |
| 3 |
Kratos Defense & Security Solutions
KTOS
|
+$9.05M |
| 4 |
Chewy
CHWY
|
+$7.97M |
| 5 |
Archer Aviation
ACHR
|
+$7.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$161M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$161M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$93.1M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$71.2M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.28% |
| 2 | Industrials | 12.21% |
| 3 | Financials | 10.78% |
| 4 | Technology | 8.99% |
| 5 | Consumer Discretionary | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QXO
1
PUT
QXO Inc
QXO
$14.7B
| $17.2M | 6.25% |
+800,000
| New | +$13.1M |
|
2
PUT
Brown & Brown
BRO
$24.6B
| $16.6M | 6.03% |
+150,000
| New | +$16.9M |
|
|
3
Eli Lilly
LLY
$1.09T
| $15.6M | 5.65% |
+20,000
| New | +$15.5M |
|
4
Core Scientific
CORZ
$6.48B
| $11.9M | 4.33% |
+700,000
| New | +$7M |
|
|
5
Kratos Defense & Security Solutions
KTOS
$9.02B
| $11.6M | 4.21% |
+250,000
| New | +$9.05M |
|
6
BridgeBio Pharma
BBIO
$16.5B
| $11M | 3.99% |
255,000
+80,000
| +46% | +$2.91M |
|
7
Solid Biosciences
SLDB
$779M
| $10.5M | 3.82% |
2,165,000
+491,588
| +29% | +$1.74M |
|
|
GLXY
8
Galaxy Digital Inc
GLXY
$3.98B
| $10.3M | 3.73% |
+470,000
| New | +$9.54M |
|
|
TTAN
9
PUT
ServiceTitan Inc
TTAN
$7.66B
| $10.2M | 3.69% |
+95,000
| New | +$10.6M |
|
10
Structure Therapeutics
GPCR
$3.39B
| $8.92M | 3.23% |
430,000
+137,138
| +47% | +$3.02M |
|
|
11
Archer Aviation
ACHR
$3.69B
| $8.68M | 3.15% |
+800,000
| New | +$7.49M |
|
|
12
Chewy
CHWY
$9.32B
| $8.52M | 3.09% |
+200,000
| New | +$7.97M |
|
|
HNGE
13
PUT
Hinge Health
HNGE
$5.77B
| $7.25M | 2.63% |
+140,000
| New | +$5.66M |
|
14
Riot Platforms
RIOT
$7.96B
| $6.78M | 2.46% |
+600,000
| New | +$5.1M |
|
15
T-Mobile US
TMUS
$198B
| $5.96M | 2.16% |
+25,000
| New | +$6.1M |
|
|
OMDA
16
Omada Health Inc
OMDA
$1.2B
| $5.49M | 1.99% |
+300,000
| New | +$5.19M |
|
17
PUT
Cipher Digital
CIFR
$8.32B
| $5.26M | 1.91% |
+1,100,000
| New | +$3.56M |
|
|
ETOR
18
eToro Group
ETOR
$3.03B
| $5.16M | 1.87% |
+77,500
| New | +$4.99M |
|
19
MakeMyTrip
MMYT
$5.1B
| $5.15M | 1.87% |
+52,500
| New | +$5.3M |
|
20
ADT
ADT
$5.33B
| $5.09M | 1.84% |
600,406
+25,406
| +4% | +$208K |
|
|
OKLO
21
Oklo
OKLO
$6.95B
| $5.04M | 1.83% |
+90,000
| New | +$3.47M |
|
|
CHYM
22
PUT
Chime Financial
CHYM
$8.53B
| $4.83M | 1.75% |
+140,000
| New | +$4.61M |
|
|
QXO.PRB
23
QXO Inc 5.50% Series B Preferred Stock
QXO.PRB
$496M
| $4.65M | 1.69% |
+75,000
| New | +$4.38M |
|
24
Vertex
VERX
$2.15B
| $4.59M | 1.66% |
+130,000
| New | +$4.95M |
|
25
Redwire
RDW
$2.04B
| $4.08M | 1.48% |
+250,000
| New | +$3.26M |
|
Similar funds
EFIC
SWMG
AAM
IFPL
RFG
KWM
NAM
GCGM
Monashee Investment Management's Q2 2025 Portfolio in Review
As of Q2 2025, Monashee Investment Management held 96 positions worth $276M, down 67% from $845M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Monashee Investment Management withdrew a net $602M in Q2 2025, closing 39 positions and reducing 2 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $161M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 5.1% a quarter earlier, followed by Industrials and Financials.
Against the trend, Monashee Investment Management opened a new position in Eli Lilly worth $15.6M.
- Monashee Investment Management's largest Q2 2025 buy was Eli Lilly: 20,000 shares worth $15.6M.
- Monashee Investment Management added most to Structure Therapeutics in Q2 2025, an estimated $3.02M increase.
- Monashee Investment Management's biggest Q2 2025 reduction was Biodesix, cutting an estimated $828K.
- Monashee Investment Management fully exited iShares Core S&P 500 ETF in Q2 2025, selling an estimated $161M.
- Monashee Investment Management's ten largest holdings make up 45% of its $276M portfolio in Q2 2025.
- Monashee Investment Management opened 49 new positions and closed 39 in Q2 2025.
- Monashee Investment Management's portfolio value fell 67% quarter-over-quarter to $276M.
Based on Monashee Investment Management's 13F filing for Q2 2025, filed 11 Aug 2025.